cipla
-
Sanofi, Cipla to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium Sanofi India and Cipla announced…
Read More » -
Cipla secures CDSCO approval to introduce ZEMDRI injection in India
The novel antibiotic plazomicin is a new intravenous (IV) minoglycoside indicated for the treatment of complicated urinary tract infections Cipla…
Read More » -
Cipla to hold 22.99% stake in the digital tech company GoApptiv
This will be Cipla’s third investment in GoApptiv, which will be made in a combination of equity shares and compulsorily…
Read More » -
Cipla partners with TEACH
To create career opportunities for hearing-impaired youth Cipla announced its partnership with the Training and Educational Centre for Hearing Impaired…
Read More » -
Cipla, Sky Air Mobility launch drone-based delivery of essential medicines in Himachal Pradesh
The use of drones will support on-time delivery of Cipla’s medicines to chemists and clinics in remote areas while minimising…
Read More » -
Cipla unveils CiplaMed 2.0 for healthcare practitioners
Cipla announced the launch of CiplaMed 2.0, an enhanced version of the industry-leading knowledge platform for the medical fraternity. In…
Read More » -
IPA’s 8th Global Pharmaceutical Quality Summit concludes in Mumbai
The focus of the event was on patient centricity and the future of manufacturing and quality The Indian Pharmaceutical Alliance…
Read More » -
Cipla signs perpetual licensing agreement with Novartis Pharma
To manufacture and market Galvus and Galvus combination brands, used in the treatment of type 2 diabetes from January 1,…
Read More » -
Cipla launches Cippoint, a point-of-care device for NCDs, infectious diseases
Cippoint, an immunofluorescence-based quantitative analyser, will allow healthcare professionals to get test results in three to 15 minutes Cipla announced…
Read More » -
Cipla EU to invest EUR 15 M in Ethris
Cipla and Ethris partner for the development of mRNA-based therapies Cipla announced that its wholly-owned UK subsidiary, Cipla (EU) (“Cipla…
Read More »